Michael Cress Net Worth

Michael Cress biography

Michael D. Cress serves as Independent Director of the Company. Mr. Cress serves as Chairman & Managing Partner of MD Cress Ventures, a national firm that owns, operates and advises companies within the healthcare sector. Michael also serves as Chairman of Rainier Healthcare. Prior to MD Cress Ventures he served as the President and CEO of the Cornerstone Healthcare Group which owns and manages hospitals throughout the country. Mr. Cress also served as Vice President of Business Development for Kindred Healthcare, a publicly traded healthcare company that owns and operates hospitals, nursing homes, rehabilitation, pharmacy and other segments of the healthcare continuum. He served as the CEO of Vencor Hospital of San Diegoand was also an Adjunct Professor for the Masters of Healthcare Administration program at the University of Kansas. Mr. Cress serves on several not-for-profit boards to include Rachel's Challenge and co-founded and serves on the board for The Neighborhood. He serves on the boards or advisory boards of several companies to include Linley Capital, BankSNB, Rainier Hospice and Sleep Research.

What is the salary of Michael Cress?

As the Independent Director of Zynex Inc, the total compensation of Michael Cress at Zynex Inc is $40,000. There are 7 executives at Zynex Inc getting paid more, with Giuseppe Papandrea having the highest compensation of $1,901,890.

How old is Michael Cress?

Michael Cress is 62, he's been the Independent Director of Zynex Inc since 2018. There are 1 older and 6 younger executives at Zynex Inc. The oldest executive at Zynex Inc is Barry Michaels, 70, who is the Independent Director.

What's Michael Cress's mailing address?

Michael's mailing address filed with the SEC is 9655 MAROON CIRCLE, , ENGLEWOOD, CO, 80112.

Insiders trading at Zynex Inc

Over the last 6 years, insiders at Zynex Inc have traded over $45,302,249 worth of Zynex Inc stock and bought 14,733 units worth $121,235 . The most active insiders traders include Thomas Sandgaard Holdings L..., Joshua R. Disbrow, eThomas Sandgaard. On average, Zynex Inc executives and independent directors trade stock every 56 days with the average trade being worth of $657,783. The most recent stock trade was executed by Anna Lucsok on 6 August 2024, trading 24,875 units of ZYXI stock currently worth $199,498.

What does Zynex Inc do?

zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.

Zynex Inc executives and stock owners

Zynex Inc executives and other stock owners filed with the SEC include:

• Giuseppe Papandrea,
  Chief Operating Officer
• Daniel Moorhead,
  Chief Financial Officer
• Thomas Sandgaard,
  Chairman of the Board, President, Chief Executive Officer
• Thomas Sandgaard,
  Founder, Pres, CEO & Chairman
• Daniel J. Moorhead,
  Chief Financial Officer
• Anna Lucsok,
  Chief Operating Officer
• Barry Michaels,
  Independent Director
• Joshua Disbrow,
  Independent Director
• Michael Cress,
  Independent Director
• Donald Gregg,
  VP of Sales and Operations - Monitoring Solutions Division
• Joachim Sandgaard,
  Information Systems Mang.
• Neil Friery,
  Pres & COO of Zynex Monitoring Solutions, Inc.
• Dave Anttila,
  Director of HR
• Steve Fox,
  VP Of Sales
• Chelle Van Burkleo,
  VP of Sales
• Dr. Raelynn Maloney Ph.D.,
  Director of Communications & Organizational Devel.
• Neil Friery,
  Remarks
• Thomas Sandgaard,
  PRESIDENT, CEO AND CHAIRMAN
• Anna Lucsok,
  CHIEF OPERATING OFFICER